Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 14/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.33 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2977557 | 0.83 | FFAR4 (0.36) | FFAR4FFAR1SLC6A1GABRA5GABRB2 | |
| SCHEMBL12614761 | 0.78 | GRM2 (0.34) | GABRA5GABRB2GABRA1GABRA4 | |
| SCHEMBL2450101 | 0.75 | FFAR4 (0.39) | FFAR4FFAR1SLC6A1GABRA5GABRB2 | |
| SCHEMBL12362126 | 0.73 | — | — | |
| SCHEMBL2362461 | 0.70 | NSD2 (0.35) | — | |
| SCHEMBL3306431 | 0.69 | FFAR4 (0.37) | FFAR4FFAR1SLC6A1GABRA5GABRB2 | |
| SCHEMBL13327501 | 0.69 | FFAR4 (0.37) | FFAR4FFAR1SLC6A1GABRA5GABRB2 | |
| SCHEMBL939927 | 0.69 | FFAR4 (0.44) | FFAR4FFAR1SLC6A1GABRA5GABRB2 | |
| SCHEMBL14272690 | 0.68 | — | — | |
| SCHEMBL3308565 | 0.68 | PABPC1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8344163-B2 | Nitrile compound and its use for control of arthropod pest | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-01 | — | — | US | disclosed |
| US-20110021627-A1 | NITRILE COMPOUND AND ITS USE FOR CONTROL OF ARTHROPOD PEST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021627-A1 | NITRILE COMPOUND AND ITS USE FOR CONTROL OF ARTHROPOD PEST | C5, OR10J3, NOX3 | FFAR4 947/4885FFAR1 2117/4885SLC6A1 4396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.